http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#head http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#provenance http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://rdf.disgenet.org/resource/gda/DGN15cf319387fa693e44e2b58f0889c9b5 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/673 http://rdf.disgenet.org/resource/gda/DGN15cf319387fa693e44e2b58f0889c9b5 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0278883 http://rdf.disgenet.org/resource/gda/DGN15cf319387fa693e44e2b58f0889c9b5 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001122 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#provenance http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://purl.org/dc/terms/description [In this open-label study involving 247 patients with metastatic melanoma and BRAF V600 mutations, we evaluated the pharmacokinetic activity and safety of oral dabrafenib (75 or 150 mg twice daily) and trametinib (1, 1.5, or 2 mg daily) in 85 patients and then randomly assigned 162 patients to receive combination therapy with dabrafenib (150 mg) plus trametinib (1 or 2 mg) or dabrafenib monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/23020132 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/dc/terms/created 2017-10-17T13:11:05+02:00 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP139197.RA6X1WUdjFXMYcoT4DwBK1zuiK2ptrjViLysD_m70xLL8 http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0